---
figid: PMC7915495__antioxidants-10-00258-g003
figtitle: Protective effects of small-molecule natural products on OS in CKD
organisms:
- Salvia miltiorrhiza
- Glycine max
- PX clade
- Olea europaea
- Vitis vinifera
- Arachis hypogaea
- Curcuma longa
- Agaricus bisporus
- Camellia sinensis
- Allium sativum
- Ginkgo biloba
- Artemisia annua
- Scutellaria baicalensis
- Panax notoginseng
- Actinidia deliciosa
- Glycyrrhiza uralensis
- Astragalus membranaceus
- Silybum marianum
- Polygonum cuspidatum
- Trigonella foenum-graecum
- Wolfiporia cocos
- Mimosa pudica
- Betula pendula
- Rhodiola rosea
- Eucommia ulmoides
- Phytolacca americana
- Alisma plantago-aquatica subsp. orientale
- Nekemias grossedentata
- Sinomenium acutum
- Litsea cubeba
- Polyporus umbellatus
- Salvia miltiorrhiza var. miltiorrhiza
- Betula pubescens
- Pachyrhizus erosus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- Ctenopharyngodon idella
- Pleocyemata sp.
- NA
pmcid: PMC7915495
filename: antioxidants-10-00258-g003.jpg
figlink: pmc/articles/PMC7915495/figure/antioxidants-10-00258-f003/
number: F3
caption: Protective effects of small-molecule natural products on OS in CKD. Osthole
  and SAA enhance the activation of the Akt/Nrf2/HO-1 signaling pathway with suppression
  of NF-kB and TGFβ1, consequently attenuating OS, inflammation, and fibrosis. OB
  induces the phosphorylation of GSK3β, which inhibits Fyn-mediated Nrf2 nuclear export,
  and activates the transcription of Nrf2-driven antioxidant genes. Expression of
  SIRT1, which inhibits NF-kB activity, and the activation of Nrf2 are enhanced by
  aucubin, melatonin, and RSV, which also upregulates SIRT3, resulting in amelioration
  of kidney injury. Dioscin upregulates SIRT3 level, promotes Nrf2, and suppresses
  Keap1 expression, resulting in inhibition of inflammation, lipid metabolism, OS,
  and kidney fibrosis. PD increases the CKIP-1 expression level and promotes the interaction
  of CKIP-1 with Nrf2, consequently activating the Nrf2-ARE antioxidative pathway.
  Allicin, AST, curcumin, EASM, EGCG, ILQ, and PQQ attenuate OS via the Nrf2/HO-1
  signaling pathway with inhibition of Keap1, and they also reduce TGFβ-mediated fibrosis
  and NF-kB-induced inflammation. In the cases of an anti-fibrotic effect of apigenin,
  ASD, baicalein, BA, CGA, CTS, ERG, OL, and SFN, AMP, antroq, artemisinin, berbeine,
  calycosin, SA, SIN, and TRIG, they are mediated not only by upregulation of the
  Nrf2/HO-1 antioxidant signaling pathway and downregulation of NF-kB-induced inflammation,
  but also via TGFβ suppression. Treatments with citral, NGR1, OA, SAL, and silibinin
  have potency for anti-apoptotic effects with regulation of Bcl2/Bax and caspase3.
  The decrease in the NLRP3 inflammasome was also observed in treatments with baicalein,
  EGCG, and OL. L-mimosine activates HIF1α, which upregulates renoprotective HIF target
  genes, such as VEGF, HO-1, and GLUT1, and decreases fibrosis markers. AMP, ampelopsin;
  Antroq, antroquinonol; ASD, akebia saponin D; AST, astaxanthin; BA, betulinic acid;
  CGA, chlorogenic acid; CTS, cryptotanshinone; EASM, ethyl acetate extract of Salvia
  miltiorrhiza; EGCG, Epigallocatechin gallate; ERG, ergone; GSK3β, glycogen synthase
  kinase 3β; HIFα, hypoxia-inducible factor α; ILQ, isoliquiritin; NGR1, notoginsenoside
  R1; OA, oleanolic acid; OB, obacunone; OL, oleuropein; PD, polydatin; PQQ, pyrroloquinoline
  quinone; RSV, resveratrol; SA, sinapic acid; SAA, salvianolic acid A; SAL, salidroside;
  SFN, sulforaphane; SIN, sinomenine; TRIG, trigonelline.
papertitle: 'Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising
  Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling.'
reftext: Md Jamal Uddin, et al. Antioxidants (Basel). 2021 Feb;10(2):258.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9010072
figid_alias: PMC7915495__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Canis lupus familiaris
- Ctenopharyngodon idella
redirect_from: /figures/PMC7915495__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7915495__antioxidants-10-00258-g003.html
  '@type': Dataset
  description: Protective effects of small-molecule natural products on OS in CKD.
    Osthole and SAA enhance the activation of the Akt/Nrf2/HO-1 signaling pathway
    with suppression of NF-kB and TGFβ1, consequently attenuating OS, inflammation,
    and fibrosis. OB induces the phosphorylation of GSK3β, which inhibits Fyn-mediated
    Nrf2 nuclear export, and activates the transcription of Nrf2-driven antioxidant
    genes. Expression of SIRT1, which inhibits NF-kB activity, and the activation
    of Nrf2 are enhanced by aucubin, melatonin, and RSV, which also upregulates SIRT3,
    resulting in amelioration of kidney injury. Dioscin upregulates SIRT3 level, promotes
    Nrf2, and suppresses Keap1 expression, resulting in inhibition of inflammation,
    lipid metabolism, OS, and kidney fibrosis. PD increases the CKIP-1 expression
    level and promotes the interaction of CKIP-1 with Nrf2, consequently activating
    the Nrf2-ARE antioxidative pathway. Allicin, AST, curcumin, EASM, EGCG, ILQ, and
    PQQ attenuate OS via the Nrf2/HO-1 signaling pathway with inhibition of Keap1,
    and they also reduce TGFβ-mediated fibrosis and NF-kB-induced inflammation. In
    the cases of an anti-fibrotic effect of apigenin, ASD, baicalein, BA, CGA, CTS,
    ERG, OL, and SFN, AMP, antroq, artemisinin, berbeine, calycosin, SA, SIN, and
    TRIG, they are mediated not only by upregulation of the Nrf2/HO-1 antioxidant
    signaling pathway and downregulation of NF-kB-induced inflammation, but also via
    TGFβ suppression. Treatments with citral, NGR1, OA, SAL, and silibinin have potency
    for anti-apoptotic effects with regulation of Bcl2/Bax and caspase3. The decrease
    in the NLRP3 inflammasome was also observed in treatments with baicalein, EGCG,
    and OL. L-mimosine activates HIF1α, which upregulates renoprotective HIF target
    genes, such as VEGF, HO-1, and GLUT1, and decreases fibrosis markers. AMP, ampelopsin;
    Antroq, antroquinonol; ASD, akebia saponin D; AST, astaxanthin; BA, betulinic
    acid; CGA, chlorogenic acid; CTS, cryptotanshinone; EASM, ethyl acetate extract
    of Salvia miltiorrhiza; EGCG, Epigallocatechin gallate; ERG, ergone; GSK3β, glycogen
    synthase kinase 3β; HIFα, hypoxia-inducible factor α; ILQ, isoliquiritin; NGR1,
    notoginsenoside R1; OA, oleanolic acid; OB, obacunone; OL, oleuropein; PD, polydatin;
    PQQ, pyrroloquinoline quinone; RSV, resveratrol; SA, sinapic acid; SAA, salvianolic
    acid A; SAL, salidroside; SFN, sulforaphane; SIN, sinomenine; TRIG, trigonelline.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Saa
  - Akt1
  - Pd
  - Plekho1
  - Tmprss11d
  - Slc17a5
  - Gsk3b
  - Nfe2l2
  - Myo6
  - Mip
  - Cga
  - Chga
  - sal
  - Sall3
  - ba
  - Gusb
  - Sfn
  - Rexo2
  - Rtn4r
  - Polr3e
  - Erg
  - Sirt1
  - Sirt3
  - Hmox1
  - Tgfb1
  - Ltbp1
  - Nfkb1
  - SAA1
  - SAA2
  - SAA4
  - AKT1
  - AKT2
  - AKT3
  - PLEKHO1
  - GOT1
  - SLC17A5
  - GSK3B
  - GABPA
  - NFE2L2
  - TTR
  - CGA
  - CHGA
  - APRT
  - MFAP1
  - ARSD
  - SFN
  - REXO2
  - EFS
  - POLR3E
  - ERG
  - SIRT1
  - SIRT3
  - HIF1A
  - EPAS1
  - HIF3A
  - HMOX1
  - TGFB1
  - TGFB2
  - TGFB3
  - NFKB1
  - Tmprss5
  - LOC403585
  - LOC751814
  - KCNH2
  - saa
  - gsk3ba
  - nfe2l2a
  - cga
  - erg
  - sirt1
  - sirt3
  - hmox1a
  - EGCG
  - curcumin
  - allicin
  - PQQ
  - RSV
  - melatonin
  - CGA
  - calycosin
  - baicalein
  - silibinin
  - AMP
  - apigenin
  - SAL
  - artemisinin
  - SFN
  - berbeine
  - citral
  - dioscin
  - L-mimosine
  - OB
  - ASD
  - SIN
  - degardation
  - fibrosis
  - inflammation
---
